| Mohinder P S Randhawa Jr, MD | |
|
911 Bypass Rd Bldg A, Pikeville, KY 41501-1689 | |
| (606) 430-2201 | |
| (606) 218-4651 |
| Full Name | Mohinder P S Randhawa Jr |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 35 Years |
| Location | 911 Bypass Rd Bldg A, Pikeville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851326482 | NPI | - | NPPES |
| 200513970A | Medicaid | OK | |
| 3289969901 | Medicaid | TX | |
| 64999568 | Medicaid | KY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pikeville Medical Center | Pikeville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pikeville Medical Center Inc | 6709790157 | 314 |
News Archive
Six of the top research centres in Catalonia have taken a step forward in their collaboration by setting up The Barcelona Institute of Science and Technology. The centres involved are: the Centre for Genomic Regulation; the Institute of Chemical Research of Catalonia; the Catalan Institute for Nanoscience and Nanotechnology; the Institute of Photonic Sciences; the High Energy Physics Institute; and the Institute for Research in Biomedicine.
The Department of Veterans Affairs (VA) has announced a new policy providing a single, uniform standard of care throughout the Department for performing laser eye surgery procedures.
Researchers in the laboratory of Dr. Jayakrishna Ambati at the University of Kentucky have discovered the first naturally occurring molecule that selectively blocks lymphatic vessel growth. In an article in the Aug. 9, 2009 online edition of Nature Medicine, they report the identification of a new molecule known as soluble VEGFR-2 that blocks lymphangiogenesis - the growth of lymphatics - but not blood vessel growth.
Researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center are reporting a potentially important discovery in the battle against one of the most devastating forms of leukemia that accounts for as many as one in five children with a particularly aggressive form of the disease relapsing within a decade.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
› Verified 7 days ago
| Entity Name | Pikeville Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528195864 PECOS PAC ID: 6709790157 Enrollment ID: O20040304001281 |
News Archive
Six of the top research centres in Catalonia have taken a step forward in their collaboration by setting up The Barcelona Institute of Science and Technology. The centres involved are: the Centre for Genomic Regulation; the Institute of Chemical Research of Catalonia; the Catalan Institute for Nanoscience and Nanotechnology; the Institute of Photonic Sciences; the High Energy Physics Institute; and the Institute for Research in Biomedicine.
The Department of Veterans Affairs (VA) has announced a new policy providing a single, uniform standard of care throughout the Department for performing laser eye surgery procedures.
Researchers in the laboratory of Dr. Jayakrishna Ambati at the University of Kentucky have discovered the first naturally occurring molecule that selectively blocks lymphatic vessel growth. In an article in the Aug. 9, 2009 online edition of Nature Medicine, they report the identification of a new molecule known as soluble VEGFR-2 that blocks lymphangiogenesis - the growth of lymphatics - but not blood vessel growth.
Researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center are reporting a potentially important discovery in the battle against one of the most devastating forms of leukemia that accounts for as many as one in five children with a particularly aggressive form of the disease relapsing within a decade.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohinder P S Randhawa Jr, MD Po Box 432, Pikeville, KY 41502-0432 Ph: (606) 430-2201 | Mohinder P S Randhawa Jr, MD 911 Bypass Rd Bldg A, Pikeville, KY 41501-1689 Ph: (606) 430-2201 |
News Archive
Six of the top research centres in Catalonia have taken a step forward in their collaboration by setting up The Barcelona Institute of Science and Technology. The centres involved are: the Centre for Genomic Regulation; the Institute of Chemical Research of Catalonia; the Catalan Institute for Nanoscience and Nanotechnology; the Institute of Photonic Sciences; the High Energy Physics Institute; and the Institute for Research in Biomedicine.
The Department of Veterans Affairs (VA) has announced a new policy providing a single, uniform standard of care throughout the Department for performing laser eye surgery procedures.
Researchers in the laboratory of Dr. Jayakrishna Ambati at the University of Kentucky have discovered the first naturally occurring molecule that selectively blocks lymphatic vessel growth. In an article in the Aug. 9, 2009 online edition of Nature Medicine, they report the identification of a new molecule known as soluble VEGFR-2 that blocks lymphangiogenesis - the growth of lymphatics - but not blood vessel growth.
Researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center are reporting a potentially important discovery in the battle against one of the most devastating forms of leukemia that accounts for as many as one in five children with a particularly aggressive form of the disease relapsing within a decade.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
› Verified 7 days ago
Abdulla A Attum, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-2201 Fax: 606-218-4651 | |
Dr. Dermot P Halpin, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-2201 Fax: 606-218-4651 |